Mitotic arrest deficient 1 (Mad1) plays a well-characterized role in the major cell-cycle checkpoint that regulates chromosome segregation during mitosis, the mitotic checkpoint (also known as the spindle assembly checkpoint). During mitosis, Mad1 recruits Mad2 to unattached kinetochores [1, 2] , where Mad2 is converted into an inhibitor of the anaphase-promoting complex/cyclosome bound to its specificity factor, Cdc20 [1, [3] [4] [5] [6] . During interphase, Mad1 remains tightly bound to Mad2 [2, 3, 7, 8] , and both proteins localize to the nucleus and nuclear pores [9, 10] , where they interact with Tpr (translocated promoter region). Recently, it has been shown that interaction with Tpr stabilizes both proteins [11] and that Mad1 binding to Tpr permits Mad2 to associate with Cdc20 [12] . However, interphase functions of Mad1 that do not directly affect the mitotic checkpoint have remained largely undefined. Here we identify a previously unrecognized interphase distribution of Mad1 at the Golgi apparatus. Mad1 colocalizes with multiple Golgi markers and cosediments with Golgi membranes. Although Mad1 has previously been thought to constitutively bind Mad2, Golgi-associated Mad1 is Mad2 independent. Depletion of Mad1 impairs secretion of a5 integrin and results in defects in cellular attachment, adhesion, and FAK activation. Additionally, reduction of Mad1 impedes cell motility, while its overexpression accelerates directed cell migration. These results reveal an unexpected role for a mitotic checkpoint protein in secretion, adhesion, and motility. More generally, they demonstrate that, in addition to generating aneuploidy, manipulation of mitotic checkpoint genes can have unexpected interphase effects that influence tumor phenotypes.
Results and Discussion
An unexpected, perinuclear localization of Mad1 (Figures S1A and S1B available online) was identified in interphase HeLa cells after immunofluorescence using an affinity purified rabbit anti-Mad1 antibody, which produces a single band on immunoblots ( Figure S1C ) [13] . A similar perinuclear localization was observed in primary murine embryonic fibroblasts (MEFs) and the breast cancer cell line MDA-MB-231 (Figures S1A and S1B). To biochemically confirm the existence of a cytoplasmic pool of Mad1, we performed a fractionation experiment to separate nuclear from cytoplasmic extract. Three nuclear markers, histone H3, lamin A, and lamin C, as well as a cytoplasmic marker (tubulin), were used to confirm that appropriate fractionation was achieved. HeLa cells, MEFs, MDA-MB-231 cells, and an additional breast cancer cell line, Cal51, all contained a cytoplasmic pool of Mad1 (Figures S1D and S1E) .
Multiple experiments were performed to test the specificity of anti-Mad1 antibodies. First, Mad1 was transiently depleted in HeLa cells using small interfering RNA (siRNA). Fractionation followed by immunoblotting using the rabbit anti-Mad1 antibody revealed that total, nuclear, and cytoplasmic pools of Mad1 were depleted ( Figure S1F ). Second, an additional antibody [14] was used to confirm the identity of Mad1. This mouse monoclonal antibody also recognizes a single band of roughly 85 kDa by immunoblotting ( Figure S1C ) that is reduced after siRNA-mediated depletion of Mad1 ( Figure S1F ). Third, stable HeLa cell lines in which Mad1 expression was knocked down constitutively (to be referred to hereafter as Mad1-KD) were generated by retroviral infection of three distinct short hairpin RNA (shRNA) sequences followed by antibiotic selection. Mad1-KD cell lines grew at rates comparable to control cells and did not have obvious delays in any stage of the cell cycle (Figures S1G-S1I). Mad1 levels were diminished, but not absent, in all three cell lines ( Figure S1J ). In Mad1-KD cell lines, the cytoplasmic pool of Mad1 became undetectable by immunofluorescence ( Figure S1K ). Fourth, fractionation experiments in parental and Mad1-KD cell lines 1-3 showed a reduction in the cytoplasmic pool of Mad1 ( Figure S1L ) as detected by both Mad1 antibodies. Fifth, both Mad1 antibodies showed a cytoplasmic fraction of YFP-tagged Mad1 ( Figure S1M ). We conclude that interphase cells contain a cytoplasmic pool of the mitotic checkpoint protein Mad1.
Cytoplasmic Mad1 Is Localized to the Golgi Perinuclear Mad1 was coincident with the centrosome (Figures 1A and 1B) , as is the Golgi apparatus [15] . Golgi organization is dependent on polymerized microtubules. Microtubule depolymerization with 12 hr (Figures 1C and 1D ) or 4 hr (Figure S2A ) of vinblastine treatment caused the Golgi to disassemble and perinuclear Mad1 to disperse.
The fungal metabolite Brefeldin A (BFA) causes rapid disassembly of the Golgi without gross perturbation of microtubules [16] [17] [18] . BFA treatment also resulted in dispersal of the perinuclear Mad1 signal ( Figures 1C and 1D ), strongly suggesting that it was localized to the Golgi. To confirm this, we tested Mad1 for colocalization with several Golgi antigens. Cytoplasmic Mad1 exhibited a similar distribution as three Golgi markers, alpha-mannosidase II (MAN-II), GM130, and Golgin 97 ( Figures 1E-1H ). Colocalization of cytoplasmic Mad1 with Golgi markers was essentially complete when all three Golgi antigens were visualized in the same cell ( Figure S2B ).
Mad1 did not colocalize with early or late endosomes labeled with Rab5A and Rab7A, respectively ( Figures S2C  and S2D ). Nor did Mad1 colocalize with RINT-1, which cycles between the Golgi and the ER ( Figure S2E ). However, partial colocalization was observed between Mad1 and Rab6A (Figure S2F) , which accumulates in both the trans-Golgi network and endosomes.
To further establish the Golgi localization of Mad1, we fractionated cytoplasmic extract over an OptiPrep density gradient. Mad1 was enriched in fractions containing the Golgi marker GM130 but was largely absent from fractions containing the ER marker Ribophorin I ( Figure 1I ). These data support the conclusion that the perinuclear cytoplasmic pool of Mad1 localizes to the Golgi apparatus.
A Mad2-free Pool of Mad1
Mad1 and Mad2 are thought to interact throughout the cell cycle. Mad2 is expressed in excess of Mad1 in yeast, Xenopus extracts, and mouse and human cells [19] [20] [21] [22] . Gel filtration analysis has revealed that Mad1 elutes in a single peak that also contains Mad2. However, Mad2 also fractionates into a second peak of the expected size for monomeric Mad2 [7, 19, 23] . Depletion of Mad2 removes all detectable Mad1 in numerous systems, whereas substantial Mad2 remains after immunoprecipitation with Mad1 [2, 13, 19] . These data suggest that the entire pool of Mad1 is bound to Mad2 throughout the cell cycle. Interestingly, however, we found that Mad2 did not cofractionate with Mad1 after sedimentation on an Optiprep gradient ( Figure 1I ). Nor did Mad2 colocalize with Golgi markers by immunofluorescence ( Figure 1J ). Thus, unlike kinetochore-and nuclear-pore-bound pools of Mad1, Golgilocalized Mad1 appears free of Mad2. 
Mad1 Functions in the Secretion of a5 Integrin
To determine whether Mad1 functions in protein trafficking, we analyzed secretion of a variety of proteins. Plasma membrane accumulation of the epidermal growth factor receptor (EGFR) was not affected in Mad1-KD cells ( Figures S2G and S2H) . Nor was accumulation of the vesicular stomatitis virus envelope glycoprotein VSVG at the plasma membrane delayed due to reduction of Mad1 ( Figures S2I and S2J and Movie S1). These data suggest that there is no global defect in protein secretion after Mad1 depletion. However, an intracellular epitope of a5 integrin coalesced near the nucleus in Mad1-KD cell lines 1-3 after fixation and permeabilization (Figure 2A , arrowheads, and Figure 2B ). To confirm that this antibody was indeed recognizing a5 integrin, we imaged single z planes from the bottom of the cell. These demonstrated the expected cellsurface staining, which was coincident with the focal adhesion marker paxillin ( Figure S3A ). Costaining with GM130 revealed that the perinuclear pool of a5 integrin was localized to the Golgi ( Figure 2C, arrowheads) .
To further examine whether a5 integrin secretion was inhibited in cells depleted of Mad1, we labeled nonpermeabilized cells with an antibody recognizing an extracellular epitope of a5 integrin. Flow cytometry revealed that substantially less a5 integrin localized to the cell surface in Mad1-KD cell lines 1-3 as compared to wild-type cells (Figures 2D and 2E) .
Secretion of other integrin subunits was then examined. Subtle perturbations in the trafficking of a1, a2, and b1 integrins were also observed in Mad1-KD cells (Figures S3B-S3F) but were less pronounced than effects on a5. mRNA levels of all four integrin subunits tested were unaffected in Mad1-KD cells ( Figure S3G ), as were protein levels of a5 ( Figure S3H ). a and b integrin subunits associate in the ER before transiting the Golgi en route to the cell surface [24] . a5 subunits exclusively pair with b1, but b1 subunits dimerize with numerous alpha chains, including a1, a2, a3, a4, and a6 [25] . Mad1 participation in the secretion of only a subset of alpha subunits may explain why a5 integrin dramatically accumulated in the Golgi after Mad1 depletion, but effects on its binding partner b1 integrin were less conspicuous.
To further examine the role of Mad1 in a5 integrin secretion, we performed coimmunoprecipitation experiments in cells expressing a5 integrin-3xFLAG and GFP-tagged Mad1. Wild-type Mad1-GFP coimmunoprecipitated with a5 integrin3xFLAG, as did a Mad1 mutant that cannot bind Mad2 (K541A/L543A) [26] and a cytoplasmic version that cannot localize to the nucleus or nuclear pores (aa 180-718 [12] ; Figure S3I ), suggesting that a complex containing Mad1 and a5 integrin facilitates a5 integrin secretion.
Two cleavage events are required to produce the mature a5 integrin on the cell surface. First, the 44 aa signal peptide is cleaved from the N terminus. The second cleavage event produces mature products of 98 and 18 kD and occurs in either the trans-Golgi network or during exocytosis [27] . To determine whether maturation of a5 integrin was affected in Mad1-depleted cells, we introduced a5 integrin-3xFLAG into control and Mad1-KD1 cells. Conversion of the precursor into the 18 kD mature form was notably impaired in Mad1-KD cells ( Figure S3J ), further supporting the conclusion that Mad1 participates in a5 integrin trafficking.
Reduction of Mad1 Impairs Cellular Attachment and
Spreading on Fibronectin a5b1 heterodimers anchor cells to the extracellular matrix (ECM) by binding fibronectin [28] . The accumulation of a5 integrin in the Golgi in Mad1-KD cells suggested that depletion of Mad1 may cause deficits in cell adhesion. To test this hypothesis, we plated wild-type and Mad1-KD cell lines 1-3 and permitted them to attach to fibronectin-coated dishes. Significantly fewer Mad1-KD cells were adherent after 30 min as compared to control cells ( Figure 2F ). To determine whether decreased secretion was responsible for the attachment defect, we removed cell-surface proteins with proteinase K before plating them on fibronectin. Mad1-KD1 cells again exhibited a defect in attachment ( Figure 2G ), confirming that impaired biosynthetic transport of newly translated a5 integrin leads to delays in cellular adhesion. In contrast, attachment to collagen, which is mediated by a variety of integrins, including a1b1 and a2b1, was not affected by reduction of Mad1 ( Figure S3K ).
To determine effects of Mad1 depletion on cell spreading, we plated wild-type and Mad1-KD HeLa cell lines 1-3 on fibronectin-coated coverslips. Within 1 hr after plating, most wild- type cells had attached to the substrate and begun spreading, whereas many more Mad1-KD cells remained rounded ( Figures 3A and 3B) . After 12 hr, 85% of wild-type HeLa cells had elongated, as compared to 8%, 5%, and 3% of Mad1-KD cell lines 1-3, respectively ( Figures 3A and 3B) . To further characterize this defect, we plated wild-type and Mad1-KD1 cells on fibronectin-coated coverslips and observed them using phase-contrast time-lapse microscopy ( Figure 3C and Movie S2). Wild-type cells blebbed and began extending and retracting filopodia-like protrusions almost immediately. Mad1-KD1 cells blebbed but did not extend protrusions. Wild-type cells were noticeably flattened and elongated at 3 hr, whereas Mad1-KD1 cells remained rounded even at 12 hr.
ECM binding by integrins results in recruitment and activation of signaling molecules such as focal adhesion kinase (FAK), which becomes phosphorylated at tyrosine 397 when active [29] . Phospho-FAK levels were significantly diminished in Mad1-KD1 cells ( Figures 3D and 3E) , consistent with a deficit in integrin-mediated signaling.
Mad1 Functions in Secretion and Attachment Are Independent of Mad2
To test whether mitotic defects could cause deficits in cell attachment and spreading, we examined cells expressing reduced levels of the mitotic checkpoint components BubR1 and Mad2. In both cases, a5 integrin did not accumulate in the Golgi (Figures S4A-S4D ). Stable reduction of Mad2 also caused no delay in cell spreading ( Figure S4E ). Together, these data support the conclusions that (1) Mad1 facilitates secretion of a5 integrin during interphase and (2) this function of Mad1 is independent of Mad2.
To further test a possible role of Mad2 in integrin secretion, we reconstituted Mad1-KD cells with shRNA-resistant Mad1 constructs. Expression of wild-type Mad1 prevented accumulation of a5 integrin in the Golgi (Figures S4F and  S4G ) and permitted Mad1-KD cells to attach and spread on fibronectin-coated dishes with normal kinetics ( Figure 3B) . Importantly, the Mad1 mutant that cannot bind Mad2 also rescued a5 integrin secretion and cellular spreading, as did the cytoplasmic Mad1 mutant (Figures 3B, S4F, and S4G ). These data demonstrate that the defects in a5 integrin secretion in Mad1-KD cells are a consequence of an interphase, cytoplasmic function of Mad1 that is independent of Mad2.
Mad1 Promotes Directional Cell Motility
During directional cell migration, the centrosome orients toward the leading edge, as does the Golgi [30, 31] . After wounding, Mad1 immunoreactivity was observed on the side of the cell adjacent to the wound edge in a pattern strikingly similar to that of the Golgi and the centrosome ( Figures 4A and 4B) .
To directly test the role of Mad1 in cell migration, we observed control and Mad1-KD1 cells by time-lapse microscopy after wound formation. Wound closure was substantially delayed in Mad1-KD cells relative to wild-type HeLa cells ( Figures 4C-4D and Movie S3). Consistent with these results, transwell experiments revealed that Mad1-KD cells were significantly impaired in their migratory ability as compared to wild-type cells ( Figures 4E and 4F ).
We were unable to generate HeLa cells uniformly overexpressing Mad1. Therefore, MDA-MB-231 cells stably expressing Mad1-YFP in response to tetracycline were used to perform the converse experiments. Cells with elevated levels of Mad1 repaired wounds more rapidly than control cells (Figures 4G-4H and Movie S4). Similarly, in transwell assays, Mad1-YFP-expressing cells exhibited enhanced migratory ability as compared to controls ( Figures 4I and 4J ). These results demonstrate that the level of Mad1 is directly related to the rate of cell motility.
We then examined the motility of single cells. Mad1-KD1 cells exhibited shortened migrational distance ( Figures 4K  and 4L ), lower directional velocity ( Figure 4M ), and reduced overall speed ( Figure 4N ) as compared to controls. Thus, individual cells exhibit impaired migration after reduction of Mad1. (K-N) Wild-type and Mad1-KD1 HeLa cells were plated in one side of a microfluidics channel in media containing 0.1% serum. Twelve hours later, 20% fetal bovine serum was added to the opposite side of the chamber. Cells were imaged every 5 min for 14 hr, and single-cell motility was tracked as in [32] . n = 60 cells per condition. Prior to this study, interphase roles of Mad1 remained largely unknown. Here, we identify a novel interphase function of Mad1 that does not involve Mad2. Endogenous Mad1 localizes to the Golgi in multiple mammalian cell types. The pool of Mad1 in the Golgi facilitates secretion of a5 integrin, which promotes cellular adhesion, spreading, and motility (Figure 4O) . These functions are compromised in cells with reduced levels of Mad1. Heightened expression of Mad1 is common in breast tumors, where it serves as a marker of poor prognosis [13] . It will now be of interest to determine whether increased Mad1 in cancer cells potentiates migration and metastasis.
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